Dreyfus/The Boston Company Small/Mid Cap Growth Fund

Scorecard
5 / 5 Stars
Lipper
5 4 4 5 1
Zacks Investment Research
2 (Buy)
Standard & Poor's
5 / 5 Stars
TheStreet.com
B+ (Buy)

Fund Holdings

Asset Allocation

% Long % Net
Cash 2.19 2.19
Stocks 90.44 90.44
Bonds 0.0 0.0
Other 0.0 0.0
Foreign Bonds 0.0 0.0
Foreign Stocks 7.37 7.37
Convertible 0.0 0.0
Preferred 0.0 0.0

Updated 01.31.2014

Top 10 Holdings

Performance as of 02.28.2014

Portfolio as of 01.31.2014

Ticker YTD Return % % Net Assets
Synopsys Inc SNPS -1.8 2.27
The Whitewave Foods Company WWAV 25.63 2.04
Airgas Inc ARG -4.71 1.85
CBRE Group Inc CBG 5.02 1.84
Microchip Technology, Inc. MCHP 1.24 1.8
Salix Pharmaceuticals, Ltd. SLXP 23.13 1.77
Jarden Corporation JAH -0.64 1.76
Pacira Pharmaceuticals, Inc. PCRX 36.65 1.61
Medivation, Inc. MDVN 11.89 1.58
NPS Pharmaceuticals Inc NPSP 14.23 1.56